Balyasny Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-62,451
| Closed | -$208K | – | 2030 |
|
|
2023
Q4 | $208K | Sell |
62,451
-113,050
| -64% | -$376K | ﹤0.01% | 1744 |
|
|
2023
Q3 | $656K | Buy |
+175,501
| New | +$656K | ﹤0.01% | 1243 |
|
|
2023
Q2 | – | Sell |
-217,045
| Closed | -$1.48M | – | 1910 |
|
|
2023
Q1 | $1.48M | Sell |
217,045
-78,832
| -27% | -$539K | ﹤0.01% | 1203 |
|
|
2022
Q4 | $2.34M | Sell |
295,877
-504,073
| -63% | -$3.99M | 0.01% | 1001 |
|
|
2022
Q3 | $7.69M | Sell |
799,950
-278,159
| -26% | -$2.67M | 0.02% | 631 |
|
|
2022
Q2 | $7.81M | Buy |
+1,078,109
| New | +$7.81M | 0.03% | 605 |
|
|
2019
Q4 | – | Sell |
-10,564
| Closed | -$214K | – | 1066 |
|
|
2019
Q3 | $214K | Sell |
10,564
-216,635
| -95% | -$4.39M | ﹤0.01% | 948 |
|
|
2019
Q2 | $5.02M | Sell |
227,199
-125,171
| -36% | -$2.77M | 0.03% | 518 |
|
|
2019
Q1 | $4.81M | Buy |
352,370
+261,269
| +287% | +$3.56M | 0.03% | 508 |
|
|
2018
Q4 | $824K | Buy |
91,101
+35,270
| +63% | +$319K | 0.01% | 857 |
|
|
2018
Q3 | $921K | Sell |
55,831
-264,492
| -83% | -$4.36M | ﹤0.01% | 987 |
|
|
2018
Q2 | $4.49M | Buy |
320,323
+305,572
| +2,072% | +$4.28M | 0.02% | 574 |
|
|
2018
Q1 | $163K | Buy |
+14,751
| New | +$163K | ﹤0.01% | 1599 |
|